About
Ph.D. and president and managing partner of MRL Ventures Fund, describing the fund as an institutional venture partner taking active board or observer roles.
Experience
- MerckPresident & Managing Partner, MRL Ventures Fundcurrent2021 β presentBoston, Massachusetts, United States
- MerckPartner, MRL Ventures Fund2018 β 2021Boston
- Myoventive, Inc.Board Directorcurrent2025 β presentSan Francisco Bay Area
- InsamoBoard Observercurrent2024 β present
- InduProBoard Directorcurrent2022 β present
- Photys TherapeuticsBoard Observercurrent2021 β present
- Mozart Therapeutics, IncBoard Directorcurrent2020 β present
- Aktis OncologyBoard Observer2024 β 2026Boston
- Tallac TherapeuticsBoard Director2021 β 2025
- Therini Bio, Inc.Board Director2024 β 2025San Francisco
- Ambagon TherapeuticsBoard Director2020 β 2024
- Caraway Therapeutics, Inc.Board Director2021 β 2023
- Carisma TherapeuticsBoard Observer2018 β 2023
- LifeMine TherapeuticsBoard Observer2021 β 2023
- HotSpot Therapeutics, Inc.Board Observer2020 β 2022
- Xilio Therapeutics, Inc.Board Observer2021
- Xilio Therapeutics, Inc.Board Director2019 β 2021
- Imago BioSciences, Inc.Board Observer2018 β 2021
- Kymera TherapeuticsBoard Observer2018 β 2020
- Wellington PartnersPrincipal2016 β 2018London / Munich
Education
- University of OxfordTechnology Spin-out Management Programme2009
- SaΓ―d Business School, University of OxfordBuilding a Business, Medical Innovation2007 β 2009
- University of GenevaDoctor of Philosophy, Cell Biology2000 β 2006
- The University of British ColumbiaBachelor of Science (Hons), Molecular Microbiology and Immunology1998 β 2000
- Capilano UniversityAssociate of Science, Science1996 β 1998
- WDHS1992 β 1996
Skills & more
Biotechnology15Biopharmaceuticals3Medical Devices5Life Sciences8Diagnostics1Healthcare1Venture Capital17Entrepreneurship11Valuation4Competitive Intelligence2Market Analysis2Due Diligence3
+10 more
LifesciencesMolecular BiologyMolecular CloningBiochemistryGeneticsCommercializationData AnalysisNeuroscienceR&DResearchLanguages English Β· French Β· Polish
From Peter's professional profile.
Same school
Also attended SaΓ―d Business School, University of Oxford235
Manuk HergnyanCo-Founder & Managing Partner at Granatus VenturesMike MoradiGeneral Partner at Cortado VenturesConnor WhitingFinance Associate at Giant Ventures Global LlpBrendan BakerPartner at Rackhouse Venture Management LpMelissaInvestor at Dig Ventures Management LimitedMorgan GerlakPartner at TCV
+ 229 more
Also attended University of Geneva43
Massimo PrelzInvestor at DN CapitalChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgErich SieberFounding General Partner at PeakBridge VCDavid MarcusInvestor at FELIX CAPITALMichelle PiontekImpact & ESG Associate at AENUPatrik BrudererCFO at CV Labs
+ 37 more
Also attended The University of British Columbia164
Joan MirallesHead of Administration & Valuation at Inveready Technology Investment GroupRares CrisanInvestor at Notable CapitalMarianne WuVenture Partner at Congruent VenturesBrendan BakerPartner at Rackhouse Venture Management LpAli KashaniVenture Partner at Think+ Ventures Management, LlcNick FitzInvestor at Juniper Ventures Management, Llc
+ 158 more
Also attended Capilano University6
Daniel DuboisInvestor at Side Door VenturesAki SiebelinkOperations Team at Autotech VenturesSarah GowePlatform Operations Manager at Forum VenturesMichelle PavlikVice President, Communications at ForesightSamantha BradleyOperations Coordinator at Raven CapitalRichard EgliSpecial Advisor & Board Member at Alacrity Canada








































